Zobrazeno 1 - 10
of 447
pro vyhledávání: '"A. H. Scheller"'
Publikováno v:
Biogeosciences, Vol 18, Pp 6093-6114 (2021)
The carbon balance of high-latitude terrestrial ecosystems plays an essential role in the atmospheric concentration of trace gases, including carbon dioxide (CO2) and methane (CH4). Increasing atmospheric methane levels have contributed to ∼ 20 % o
Externí odkaz:
https://doaj.org/article/af2e18a74fce481cacdfd0b8c5d34713
Autor:
Stefan H. Scheller, Yasmine Rashad, Fayez M. Saleh, Kurtis A. Willingham, Antonia Reilich, Dong Lin, Reza Izadpanah, Eckhard U. Alt, Stephen E. Braun
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Transplanting HIV-1 positive patients with hematopoietic stem cells homozygous for a 32 bp deletion in the chemokine receptor type 5 (CCR5) gene resulted in a loss of detectable HIV-1, suggesting genetically disrupting CCR5 is a promising approach fo
Externí odkaz:
https://doaj.org/article/cdd5d9185f5b4533babba21b5503c30e
Autor:
Jagath R. Junutula, Paul Polakis, Richard H. Scheller, Mark S. Dennis, Deepak Sampath, Jo-Anne Hongo, Helga Raab, Katherine R. Kozak, Aimee Fourie-O'Donohue, Ron Firestein, Robert Piskol, Eric Cheng, Mary Ann T. Go, Kirsten A. Poon, Fiona Zhong, Rachana Ohri, Coenraad Kuijl, Dongwei Li, Melissa M. Schutten, Meredith Hazen, Yvonne Chen, Lisa M. Crocker, Sunil Bhakta
Figure S1. Validation of anti-GFRA1 antibodies (R&D systems and GNE-8H6) for the use of Immunohistochemistry (IHC) analysis; Figure S2. ELISA analyses to test binding specificity of anti-GFRA1 antibodies to GFRA1 (A) and GFRA2 (B) extra cellular doma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::100a6557ca8c0f2a229a1ced8e41d71e
https://doi.org/10.1158/1535-7163.22505118
https://doi.org/10.1158/1535-7163.22505118
Autor:
Jagath R. Junutula, Paul Polakis, Richard H. Scheller, Mark S. Dennis, Deepak Sampath, Jo-Anne Hongo, Helga Raab, Katherine R. Kozak, Aimee Fourie-O'Donohue, Ron Firestein, Robert Piskol, Eric Cheng, Mary Ann T. Go, Kirsten A. Poon, Fiona Zhong, Rachana Ohri, Coenraad Kuijl, Dongwei Li, Melissa M. Schutten, Meredith Hazen, Yvonne Chen, Lisa M. Crocker, Sunil Bhakta
Luminal A (hormone receptor-positive) breast cancer constitutes 70% of total breast cancer patients. In an attempt to develop a targeted therapeutic for this cancer indication, we have identified and characterized Glial cell line–Derived Neurotroph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ebbf88322d045b6d0c4b08c2c22021d
https://doi.org/10.1158/1535-7163.c.6537960.v1
https://doi.org/10.1158/1535-7163.c.6537960.v1
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 1 from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c0d912b911193a89f8c41d6660b15e7
https://doi.org/10.1158/1078-0432.22442970
https://doi.org/10.1158/1078-0432.22442970
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Purpose: Antibody drug conjugates (ADCs) combine the ideal properties of both antibodies and cytotoxic drugs by targeting potent drugs to the antigen-expressing tumor cells, thereby enhancing their antitumor activity. Successful ADC development for a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d28facc06955b3988a108b08483c5b9
https://doi.org/10.1158/1078-0432.c.6519576
https://doi.org/10.1158/1078-0432.c.6519576
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Methods, Figure Legends 1-3, Tables 1A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234fb526b489c22c090c1bc0298163b4
https://doi.org/10.1158/1078-0432.22442958.v1
https://doi.org/10.1158/1078-0432.22442958.v1
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 3C-D from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f44961c6a240c1b49072e5ec02c2e71
https://doi.org/10.1158/1078-0432.22442961
https://doi.org/10.1158/1078-0432.22442961
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 2 from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::780049c9955d6fc471ce12dcf37886bc
https://doi.org/10.1158/1078-0432.22442967
https://doi.org/10.1158/1078-0432.22442967
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 3A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecc2f3a7760b11a7fc648936743bf45a
https://doi.org/10.1158/1078-0432.22442964
https://doi.org/10.1158/1078-0432.22442964